22 May 2013
Keywords: GlaxoSmithKline, 2009 financial results, R&D refocus, Emerging markets,
Article | 05 February 2010
Although not confirming recent speculation of 3,000 or so job cuts, UK headquartered drugs giant GlaxoSmithKline revealed that it plans to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.